Pouch Easier to Get Human Trial Approval than Cell EncapsulSernova is far ahead of the game because cell pouch is easier to get human trial approval than cell encapsulation. They already have human trial approval, but the second stage approval for adding Sertolin should not be a problem because the cell pouch can simply be removed if there's a problem. But the FDA and Health Canada would be reluctant and take many years to get their human trial approval on cell encapsulation or cell re-engineering, because if something went wrong, you can't pull those cells out of the body like a cell pouch. Two years ago, Philip said the plan was to have this on the mass market in 5 years. That would be 3 years from today. Give them a bit of slack, and if it's on the market 5 years from today, none of those other research Institutes are that close. Also, a lot of those other researchers are not even with a company on the stock market. Bay Street and Wall Street want to make money and will cheer for the company that's closer and on the stock market. In the same time helping Sernova achieve it faster with more capital.